`Filed: October 11, 2016
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`AMNEAL PHARMACEUTICALS LLC and PAR PHARMACEUTICAL, INC.,
`Petitioners,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC.,
`Patent Owner.
`
`_____________________
`
`Case IPR2015-01903
`Patent 8,731,963
`_____________________
`
`MOTION FOR PRO HAC VICE ADMISSION
`UNDER 37 C.F.R. § 42.10
`
`Mail Stop "PATENT BOARD"
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`IPR2015-01903—Patent No. 8,731,963
`Petitioner’s Motion for PHV Admission
`
`Petitioner Par Pharmaceutical, Inc. (“Petitioner”) files this motion for pro
`
`hac vice admission under 37 C.F.R. § 42.10(c), as authorized in the Notice of
`
`Filing Date Accorded, Paper No. 5. The Board requires that such motions be filed
`
`in accordance with the “Order – Authorizing Motion for Pro Hac Vice Admission”
`
`in Case IPR2013-00639, Paper 7 (“Order”).
`
`Petitioner respectfully requests that the Board recognize Mr. Gary A. Coad
`
`as counsel pro hac vice during this proceeding.
`
`1.
`
`Time for Filing
`This motion for pro hac vice admission is filed no sooner than twenty-one
`
`(21) days after service of the petition, as required by the Order.
`
`2.
`
`Statement of Facts
`
`The following statement of fact shows that there is good cause for the Board
`
`to recognize Mr. Coad pro hac vice.
`
`Mr. Coad is an experienced litigation attorney and has been involved in
`
`numerous litigations involving patent infringement in District Courts across the
`
`country. Mr. Coad’s biography is attached as Exhibit A to his declaration.
`
`Further, counsel for Patent Owner does not oppose Mr. Coad appearing pro
`
`hac vice during this proceeding.
`
`Therefore, Petitioner respectfully submits that there is good cause for the
`
`Board to recognize Mr. Coad as counsel pro hac vice during this proceeding.
`
`1
`
`
`
`IPR2015-01903—Patent No. 8,731,963
`Petitioner's Motion for PHV Admission
`
`3.
`
`Declaration of Individual Seeking to Appear
`
`This Motion for Pro Hac Vice Admission is accompanied by the declaration
`
`of Mr. Gary A. Coad, as required by authorization of the Board.
`
`Date: October 11, 2016
`
`Respectfully submitted,
`
`egis ration No. 42,387
`ARENT FOX LLP
`1717 K Street, NW
`Washington, DC 20006
`202.857.6000
`Attorney for Petitioner
`Par Pharmaceutical, Inc.
`
`2
`
`2
`
`
`
`IPR2015-01903—Patent No. 8,731,963
`Petitioner’s Motion for PHV Admission
`
`DECLARATION OF MR. GARY A. COAD IN SUPPORT OF
`MOTION FOR PRO HAC VICE ADMISSION
`
`I, Gary A. Coad, am over eighteen years of age and would be competent to
`
`testify as to the matters set forth herein if called upon to do so.
`
`1.
`
`I am an attorney in the law firm of Arent Fox LLP. I have over four
`
`(4) years of experience as a patent litigator and have represented clients in
`
`numerous patent litigation cases in various United States District Courts, the
`
`International Trade Commission, and the Patent Trial and Appeal Board.
`
`2. My educational and professional backgrounds make me familiar with
`
`the subject matter at hand. See attached Exhibit A. I am comfortable and
`
`experienced with technically and legally complex matters such as will be present
`
`in this proceeding.
`
`3.
`
`I am a member in good standing of the state bar of Virginia and the
`
`bar of the District of Columbia, as well as the United States District Court for the
`
`Eastern District of Virginia.
`
`4.
`
`I have not been suspended or disbarred from practice before any court
`
`or administrative body.
`
`5.
`
`I have never had an application for admission to practice before any
`
`court or administrative body denied.
`
`6.
`
`No sanction or contempt citation has been imposed against me by any
`
`court or administrative body.
`
`1
`
`
`
`IPR2015-01903—Patent No. 8,731,963
`Petitioner's Motion for PHV Admission
`
`7.
`
`I have applied to appear pro hac vice in the following proceedings
`
`before the USPTO in the last three years:
`
`Umicore AG & Co. KG v. BASF Corporation
`Umicore AG & Co. KG v. BASF Corporation
`Umicore AG & Co. KG v. BASF Corporation
`Umicore AG & Co. KG v. BASF Corporation
`
`Case IPR2015-01121
`Case IPR2015-01123
`Case IPR2015-01124
`Case IPR2015-01125
`
`8.
`
`I have read and will comply with the Office Patent Trial Practice
`
`Guide and the Board's Rules of Practice for Trials set forth in part 42 of 37 C.F.R.
`
`9.
`
`I will be subject to the USPTO Rules of Professional Conduct set
`
`forth in 37 C.F.R. §§ 11.101 et seq. and disciplinary jurisdiction under 37 C.F.R. §
`
`11.19(a).
`
`I declare under penalty of perjury that the foregoing Declaration s true and
`
`correct.
`
`Date: October 11, 2016
`
`ary A. Coad
`ARENT FOX LLP
`1717 K Street NW
`Washington, DC 20006
`202.857.6000
`
`2
`
`2
`
`
`
`Exhibit A
`
`Exhibit A
`
`
`
`10/10/2016
`
`Gary A. Coad | Arent Fox LLP, Law Firm
`
`CONNECT WITH US
`
`Gary A. Coad
`
`Gary A. Coad
`Associate
`Washington, DC
`
`T 202.857.6057
`E gary.coad@arentfox.com
`
`Download vCard
`
`Bar & Court
`Admissions
`District of Columbia Bar
`Virginia Bar
`Eastern District Virginia
`
`Education
`
`University of New Hampshire
`School of Law, JD (cum
`laude) , 2012
`Mercyhurst University, BS,
`2009
`
`Gary A. Coad is an associate in the Washington, D.C. office and a member of the
`Intellectual Property practice. He focuses on patent litigation, including district court
`litigation and Section 337 investigations before the United States International Trade
`Commission.
`
`Mr. Coad has experience with a wide array of technologies, including pharmaceuticals,
`pharmaceutical delivery systems and medical devices, organic electroluminescent
`devices and materials, wearable technologies, print management and cost recovery
`systems, semiconductor manufacturing and packaging, and touchscreen input systems.
`
`Mr. Coad received his J.D., cum laude, from the University of New Hampshire School of
`Law, where he was a member of IDEA: The Intellectual Property Law Review and was
`recognized as a Franklin Pierce Intellectual Property Law Scholar. Mr. Coad graduated
`from Mercyhurst University in 2009 with a B.S. in Chemistry.
`Previous Work
`
`Prior to joining Arent Fox, Mr. Coad served as a patent litigation associate at a large
`international law firm for three years. Mr. Coad was also an intern in the Office of Unfair
`Import Investigations for the United States International Trade Commission.
`
`Practices
`
`Intellectual Property
`Patent
`HatchWaxman
`Litigation
`Patent Litigation
`Patent Transactional
`Section 337 ITC Litigation
`
`https://www.arentfox.com/people/garycoad#.V_vwPvkrKUk
`
`1/1
`
`
`
`IPR2015-01903—Patent No. 8,731,963
`Certification of Service
`
`CERTIFICATION OF SERVICE (37 C.F.R. §§ 42.6(e), 42.105(a))
`
`The undersigned hereby certifies that the above-captioned MOTION FOR
`
`PRO HAC VICE ADMISSION UNDER 37 C.F.R. § 42.10 was served in its
`
`entirety on October 11, 2016, upon the following parties via Electronic Mail:
`
`Donald B. Cohran
`JONES DAY
`North Point
`901 Lakeside Avenue
`Cleveland, OH 44114
`dcochran@j onesday. corn
`
`F. Dominic Cerrito
`Evangeline Shih
`Gabriel P. Brier
`Frank C. Calvosa
`QUINN EMANUEL URQUHART &
`SULLIVAN LLP
`51 Madison Avenue
`22nd Floor
`New York, NY 10010
`nickcerrito@quinnemanuel.cona
`evangelineshih@quirmemanuel.com
`gabrielbrier@quinnemanuel.com
`frankcalvosa@quinnemanuel.com
`
`Date: October 11, 2016
`
`Respectfully submitted,
`
`ARENT FOX LLP
`1717 K Street, NW
`Washington, DC 20006
`202.857.6000
`
`r an
`R stration No. 42,387
`ARENT FOX LLP
`1717 K Street, NW
`Washington, DC 20006
`202.857.6000
`Attorney for Petitioner
`Par Pharmaceutical, Inc.